Clinical and Economic Assessment of Robot‐Assisted Radical Prostatectomy With the Hinotori Surgical System: Insights From a Japanese Single‐Centre Study
The International Journal of Medical Robotics and Computer Assisted Surgery · 2025-06 · 21 (3)
DOI: 10.1002/rcs.70084 ↗Abstract
ABSTRACT Background We investigated the clinical and economic outcomes of robot‐assisted radical prostatectomy (RARP) using the hinotori surgical system (H‐RARP). Methods The analysis was conducted on 76 and 68 patients who underwent RARP using the da Vinci surgical system (D‐RARP) and H‐RARP, respectively. Safety, oncological, and functional outcomes were compared between H‐RARP and D‐RARP. Risk factors influencing medical costs in RARP were identified via linear regression analysis. Results Except for longer operative time in H‐RARP, clinical outcomes were comparable. The median medical costs per case were $12,426.8 for D‐RARP and $12,548.9 for H‐RARP. Operative time (coefficient: 0.0002, p < 0.001), pathological T stage (coefficient: 0.023, p = 0.030), and postoperative hospital stay (coefficient: 0.028, p < 0.001) were significant factors affecting medical costs; in contrast, the type of robot‐assisted surgical system was not a significant factor. Conclusions H‐RARP offers clinical outcomes comparable to those of D‐RARP while maintaining equivalent medical costs.
EUVIMED